Nutrition Valuation Multiples

Explore the DealMatrix Industry Multiple for Nutrition: EV/Sales and EV/EBITDA across all regions.

Coverage
EV/Sales; EV/EBITDA
Valuation Multiples
Private Market
Benchmarks
All Regions
Industry Multiple
Quarterly
Updated

Nutrition

Nutrition companies build products, services, and platforms that improve diet and metabolic health. Private-market valuations reflect repeat purchase, outcome evidence, and the strength of brand and retention.

The category spans nutrition products and supplements, personalised nutrition, and metabolic-health platforms.

Key Drivers
→
Repeat Purchase & Retention
Subscription and repeat purchase reduce reliance on paid acquisition.
→
Outcome Evidence
Demonstrated health outcomes make the product defensible and premium.
→
Brand Strength
A trusted brand sustains pricing power and organic growth.
→
Margin Structure
Healthy gross margins on products and services support durable value.

Sector

Nutrition

Health & Life Sciences

Sector tracked since

2000

25+ years of data

EV/SALES & EV/EBITDA FOR

All Regions

Modelled independently via proprietary econometric approach

UPDATE FREQUENCY

Quarterly

Data updates & model improvement

Nutrition Valuation Multiples

DealMatrix Industry Multiple, Nutrition, All Regions
EV/Sales 2.4×EV/EBITDA 14.0×as of 31 Dec 2025

Derived from listed-company data through the DealMatrix model and industry mapping, before stage adjustment.

A Series A Nutrition company in Europe is priced differently. Get the DealMatrix Multiple for your stage and region.

Run Nutrition for your stage and region →

The Venionaire DealMatrix Multiples Model

DealMatrix multiples are proprietary private-market benchmarks, derived through a six-step model that translates public capital-market index comparables into private-market segments and funding stages, adjusted for macroeconomic conditions.

The model produces three components: The reported public multiple, the model-predicted multiple, and the lower bound predicted multiple averaged into the DealMatrix Composite, then adjusted for region and funding stage. The methodology follows the IPEV Guidelines 2025.

Model Architecture
01
Data Acquisition
200 Public Indices
02
Statistical Cleaning
Outliers & Gaps
03
Econometric Modelling
Macro & Averaging
04
Regional Adjustment
6 Regions
05
Industry Weighting
150 Categories
06
Stage Adjustment
Pre-Seed → Series E
Final DealMatrix Multiple
EV/Sales and EV/EBITDA by sector, region and stage
Following IPEV Guidelines 2025, updated each quarter
Latest Nutrition Deals

Similar industries to explore

Valuation benchmarks differ across industries as business models, growth rates and margins vary. Explore the sectors most related to Nutrition to see how their EV/Sales and EV/EBITDA multiples compare.

Nutrition Valuation Multiples — FAQ

What is the valuation multiple for Nutrition companies?

As of 31 December 2025, the DealMatrix Industry Multiple for Nutrition across all regions is 2.4× EV/Sales and 14.0× EV/EBITDA. It is derived from listed-company data through the DealMatrix model and industry mapping, before stage adjustment.

Why does a Nutrition company at my stage or in my region get a different multiple?

The industry multiple covers all regions and is shown before stage adjustment. A Series A Nutrition company in Europe is priced differently. The DealMatrix platform gives the multiple for your stage and region.

What is the difference between EV/Sales and EV/EBITDA for Nutrition?

EV/Sales (enterprise value ÷ revenue) is used for high-growth Nutrition companies that are not yet profitable, while EV/EBITDA (enterprise value ÷ operating profit) applies to mature, profitable ones. Early-stage companies are usually benchmarked on EV/Sales.

How is the Nutrition industry multiple calculated?

It is derived from listed-company data through the DealMatrix model and industry mapping. The methodology follows the IPEV Guidelines 2025.

How current is this Nutrition figure?

The figure shown is as of 31 December 2025. Current-quarter figures are available in the DealMatrix platform.

Start using data-driven private equity/venture capital multiples.